doi.org/10.1016/S0090-4295(98)00542-1, hdl.handle.net/1765/56022
Urology
Department of Pathology

van der Kwast, T., Têtu, B., Candas, B., Gomez, J.-L., & Cusan, L. (1999). Prolonged neoadjuvant combined androgen blockade leads to a further reduction of prostatic tumor volume: Three versus six months of endocrine therapy. Urology, 53(3), 523–529. doi:10.1016/S0090-4295(98)00542-1